The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4)

EDITORIAL  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):245-7

Communicating across the boundaries

Duatti A., Smith S. V.

PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):248-64

Advances in cancer therapy with radiolabeled monoclonal antibodies

Goldenberg D. M., Sharkey R. M.

Abstract PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):265-71

Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate

Bakker W. H., Breeman W. A. P., Kwekkeboom D. J., De Jong L. C., Krenning E. P.

Abstract PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):272-87

Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy

Pelosi G., Volante M., Papotti M., Sonzogni A., Masullo M., Viale G.

Abstract PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):288-95

Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides

Cremonesi M., Ferrari M., Bodei L., Tosi G., Paganelli G.

Abstract PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):296-309

Vascular tumor targeting

Ahlskog J., Paganelli G., Neri D.

Abstract PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):310-21

Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy

Panigone S., Nunn A. D.

Abstract PDF

ADVANCES IN RADIONUCLIDE THERAPY  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):322-9

Current status and perspectives in alpha radioimmunotherapy

Chérel M., Davodeau F., Kraeber-Bodéré F., Chatal J. F.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):330-3

Platelet function after single [153Sm]EDTMP therapy in prostate cancer

Weiss K., Palumbo B., Palumbo I., Palumbo R., Granegger S., Hiltunen J., Sinzinger H.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):334-43

Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods

Sobal G., Resch U., Tatzber F., Sinzinger H.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):344-7

Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan

Giovanella L., Squin N., Ghelfo A., Ceriani L.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):348-54

Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma

Zerva B., Koutsikos J., Palestidis C., Kounadi E., Gerali S.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):355-62

[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast

Minutoli F., Herberg A., Spadaro P., Restifo Pecorella G., Baldari S., Aricò D., Altavilla G., Baldari S.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):363-70

Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications

Courbon F., Caselles O., Zerdoud S., Duthil P., Regis H., Berry I., Caron P.

Abstract PDF